Literature DB >> 14660773

The US tobacco control community's view of the future of tobacco harm reduction.

K E Warner1, E G Martin.   

Abstract

OBJECTIVE: Tobacco harm reduction (THR) has garnered recent attention due to the introduction of novel nicotine delivery products ostensibly intended to reduce risk for inveterate cigarette smokers. This study evaluates the grassroots tobacco control community's knowledge, opinions, and beliefs about THR.
DESIGN: A web/mail survey conducted in October and November 2002, with a telephone survey of a sample of non-respondents.
SUBJECTS: The 2833 US based registrants for the 2001 National Conference on Tobacco or Health. MAIN OUTCOME MEASURES: Respondents' awareness of THR, perception of its importance, support for regulation, and perception of which THR products should be recommended to inveterate cigarette smokers.
RESULTS: 70% of respondents were aware of THR but respondents had low recognition of specific products at the forefront of the debate, such as Swedish snuff. Half believe THR will reduce smoking cessation and cause nicotine experimentation by children; 63% anticipate unintended adverse side effects. More expect THR to have a negative than a positive impact on health. Large majorities support government regulation of THR and conventional tobacco products, but fewer than 30% expect legislation regulating either. Most would recommend nicotine patches (76%) and gum (70%) to inveterate smokers, but no other product was supported by a majority. Scientists are more supportive of THR than activists, while respondents focusing on national/international issues are more supportive than those concentrating on local/state issues.
CONCLUSIONS: Many members of the US tobacco control community are unaware of the THR "movement", while others possess only rudimentary familiarity with it. If and as THR achieves an increasingly prominent role on the tobacco-or-health scene, this community will have to become educated about THR, and be prepared to advocate for regulatory policies that will maximise the potential for positive outcomes. The potential for negative outcomes remains significant.

Entities:  

Mesh:

Year:  2003        PMID: 14660773      PMCID: PMC1747785          DOI: 10.1136/tc.12.4.383

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  5 in total

1.  Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction.

Authors:  L T Kozlowski; A A Strasser; G A Giovino; P A Erickson; J V Terza
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

2.  Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress?

Authors:  J E Henningfield; K O Fagerstrom
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

3.  Treatment of tobacco dependence: innovative regulatory approaches to reduce death and disease: preface.

Authors:  K E Warner; C C Peck; R L Woosley; J E Henningfield; J Slade
Journal:  Food Drug Law J       Date:  1998       Impact factor: 0.619

4.  The emerging market for long-term nicotine maintenance.

Authors:  K E Warner; J Slade; D T Sweanor
Journal:  JAMA       Date:  1997-10-01       Impact factor: 56.272

5.  European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.

Authors:  C Bates; K Fagerström; M J Jarvis; M Kunze; A McNeill; L Ramström
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

  5 in total
  9 in total

Review 1.  Tobacco harm reduction involves more than cigarette harm reduction.

Authors:  Gary A Giovino
Journal:  Am J Public Health       Date:  2004-08       Impact factor: 9.308

Review 2.  "Not safe" is not enough: smokers have a right to know more than there is no safe tobacco product.

Authors:  L T Kozlowski; B Q Edwards
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

3.  New tobacco products: do smokers like them?

Authors:  R S Caraballo; L L Pederson; N Gupta
Journal:  Tob Control       Date:  2006-02       Impact factor: 7.552

Review 4.  Asian herbal-tobacco cigarettes: "not medicine but less harmful"?

Authors:  Aiyin Chen; Stanton Glantz; Elisa Tong
Journal:  Tob Control       Date:  2007-04       Impact factor: 7.552

5.  Extracts from presumed "reduced harm" cigarettes induce equivalent or greater toxicity in antigen-presenting cells.

Authors:  Robert Vassallo; Lei Wang; Yoshimi Hirano; Paula Walters; Diane Grill
Journal:  Toxicology       Date:  2015-07-10       Impact factor: 4.221

6.  Tobacco harm reduction: what do the experts think?

Authors:  E G Martin; K E Warner; P M Lantz
Journal:  Tob Control       Date:  2004-06       Impact factor: 7.552

7.  Characteristics of current and recent former smokers associated with the use of new potential reduced-exposure tobacco products.

Authors:  Mark Parascandola; Erik Augustson; Allison Rose
Journal:  Nicotine Tob Res       Date:  2009-11-13       Impact factor: 4.244

8.  Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brands.

Authors:  Mark Parascandola; Erik Augustson; Mary E O'Connell; Stephen Marcus
Journal:  Nicotine Tob Res       Date:  2009-06-18       Impact factor: 4.244

9.  Is low-nicotine Marlboro snus really snus?

Authors:  Jonathan Foulds; Helena Furberg
Journal:  Harm Reduct J       Date:  2008-02-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.